Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Journal of the International Association of Providers of AIDS Care
|
October 17, 2014
Daptomycin experience in patients with human immunodeficiency virus and resistant gram-positive infections
Jihad Slim, Humberto Jimenez, Darren Culshaw, et al.
Molecular and Cellular Biochemistry
|
July 1, 2026
Galectin-3, transforming growth factor beta 1, and brain natriuretic peptide in cardiac remodeling under hyperlipidemic and hyperglycemic stress
Hina Patel, Angelie Pathak, Resmi Rajalekshmi, et al.
The American Journal of Emergency Medicine
|
November 26, 2016
The X factor: Lack of bleeding after an acute apixaban overdose
Scott M Leikin, Hina Patel, Katherine L Welker, et al.
Molecular Cancer Therapeutics
|
September 23, 2021
Anti-VEGF Antibody Protects against Alveolar Exudate Leakage Caused by Vascular Hyperpermeability, Resulting in Mitigation of Pneumonitis Induced by Immunotherapy
Toshiki Iwai, Masamichi Sugimoto, Hina Patel, et al.
The Western Journal of Emergency Medicine
|
March 18, 2022
Association of Suicide Attempt with Stimulant Abuse in California Emergency Departments in 2011: A Study of 10 Million ED Visits
Shahram Lotfipour, Nikhil Shah, Hina Patel, et al.
European Journal of Clinical Pharmacology
|
January 8, 2021
Letter to the editor: Model-based simulation to support the extended dosing regimens of atezolizumab
Benjamin Wu, Stephanie N Liu, Marcus Ballinger, et al.
Journal of the Endocrine Society
|
December 19, 2018
Continuous Etomidate Infusion for the Management of Severe Cushing Syndrome: Validation of a Standard Protocol
Ty B Carroll, William J Peppard, David J Herrmann, et al.
Pharmaceutical Medicine
|
December 8, 2021
Effectiveness of Additional Risk Minimization Measures for Atezolizumab in the European Union
Hina Patel, Thanh G N Ton, Jessica Davies, et al.
Cancer Chemotherapy and Pharmacology
|
September 23, 2019
Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
Kari M Morrissey, Mathilde Marchand, Hina Patel, et al.
The Journal of Arthroplasty
|
May 18, 2011
Post damage in contemporary posterior-stabilized tibial inserts: influence of implant design and clinical relevance
, Francisco J Medel, Steven M Kurtz, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Journal of the International Association of Providers of AIDS Care
|
October 17, 2014
Daptomycin experience in patients with human immunodeficiency virus and resistant gram-positive infections
Jihad Slim, Humberto Jimenez, Darren Culshaw, et al.
Molecular and Cellular Biochemistry
|
July 1, 2026
Galectin-3, transforming growth factor beta 1, and brain natriuretic peptide in cardiac remodeling under hyperlipidemic and hyperglycemic stress
Hina Patel, Angelie Pathak, Resmi Rajalekshmi, et al.
The American Journal of Emergency Medicine
|
November 26, 2016
The X factor: Lack of bleeding after an acute apixaban overdose
Scott M Leikin, Hina Patel, Katherine L Welker, et al.
Molecular Cancer Therapeutics
|
September 23, 2021
Anti-VEGF Antibody Protects against Alveolar Exudate Leakage Caused by Vascular Hyperpermeability, Resulting in Mitigation of Pneumonitis Induced by Immunotherapy
Toshiki Iwai, Masamichi Sugimoto, Hina Patel, et al.
The Western Journal of Emergency Medicine
|
March 18, 2022
Association of Suicide Attempt with Stimulant Abuse in California Emergency Departments in 2011: A Study of 10 Million ED Visits
Shahram Lotfipour, Nikhil Shah, Hina Patel, et al.
European Journal of Clinical Pharmacology
|
January 8, 2021
Letter to the editor: Model-based simulation to support the extended dosing regimens of atezolizumab
Benjamin Wu, Stephanie N Liu, Marcus Ballinger, et al.
Journal of the Endocrine Society
|
December 19, 2018
Continuous Etomidate Infusion for the Management of Severe Cushing Syndrome: Validation of a Standard Protocol
Ty B Carroll, William J Peppard, David J Herrmann, et al.
Pharmaceutical Medicine
|
December 8, 2021
Effectiveness of Additional Risk Minimization Measures for Atezolizumab in the European Union
Hina Patel, Thanh G N Ton, Jessica Davies, et al.
Cancer Chemotherapy and Pharmacology
|
September 23, 2019
Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
Kari M Morrissey, Mathilde Marchand, Hina Patel, et al.
The Journal of Arthroplasty
|
May 18, 2011
Post damage in contemporary posterior-stabilized tibial inserts: influence of implant design and clinical relevance
, Francisco J Medel, Steven M Kurtz, et al.
Page
of 3